Early prediction of a long-term outcome by neutrophil-FISH in patients with CML receiving imatinib mesylate.
Takahashi
Naoto
N
Kameoka
Yoshihiro
Y
Tagawa
Hiroyuki
H
Saitoh
Hirobumi
H
Yoshioka
Tomoko
T
Fujishima
Naohito
N
Kitabayashi
Atsushi
A
Takahashi
Kaoru
K
Hirokawa
Makoto
M
Sawada
Kenichi
K
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D020732:Cytogenetic Analysis; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000175:diagnosis* / Q000188:drug therapy*; D009504:Neutrophils / Q000187:drug effects / Q000473:pathology*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate